AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Truqap (capivasertib) — Worldwide product sales by Year
Truqap (capivasertib) — Worldwide product sales ($M) ($M)
AstraZeneca Truqap (capivasertib) — Worldwide product sales: $728M in FY2025, up 69.3% from a year earlier.
Where the FY2025 figure comes from
“|| Truqap | 728 | 69 | 68 | 586 | 44 | 23 | n/m | n/m | 85 | n/m | n/m | 34 | n/m | n/m”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Truqap (capivasertib) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 728 | +69.3% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 430 | +7,066.7% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 6 | – | Form 6-K FY2023Q4 Earnings Release ↗ |
Breakdown
What makes up truqap (capivasertib) — Worldwide product sales
- Truqap (capivasertib) — Worldwide YoY actual (%)69.0% · FY2025
- Truqap (capivasertib) — Worldwide YoY CER (%)68.0% · FY2025
- Truqap (capivasertib) — US product sales ($M)586 · FY2025
- Truqap (capivasertib) — Emerging Markets product sales ($M)23 · FY2025
- Truqap (capivasertib) — Europe product sales ($M)85 · FY2025
- Truqap (capivasertib) — Established RoW product sales ($M)34 · FY2025
Cite this data
StockData. (2026). AstraZeneca Truqap (capivasertib) — Worldwide product sales ($M), annual FY2023–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-truqap-world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.